Helicobacter pylori and gastric cancer.

作者: Hidekazu Suzuki , Eisuke Iwasaki , Toshifumi Hibi

DOI: 10.1007/S10120-009-0507-X

关键词:

摘要: Helicobacter pylori is now well known as an important pathogen related to the development of gastric cancer. However, some clinicians still doubt causal association H. with To summarize recent clinical data on link between and cancer, we reviewed articles published over past 3 years, after award Nobel Prize for Physiology or Medicine Drs. J.R. Warren B.J. Marshall first culture isolation investigation their relevance peptic ulcer disease. This updated summary relationship cancer highlights strong organism suggests eradication this bacterial infection a possible prophylactic measure against lethal malignancy. At present, researchers in field emphasize need from human stomach.

参考文章(66)
J Robin Warren, Barry Marshall, UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS The Lancet. ,vol. 321, pp. 1273- 1275 ,(1983) , 10.1016/S0140-6736(83)92719-8
Hiroshi Seno, Kiichi Satoh, Shingo Tsuji, Takayuki Shiratsuchi, Yosuke Harada, Nobuyuki Hamajima, Kentaro Sugano, Sunao Kawano, Tsutomu Chiba, Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan : Comprehensive analysis of 207 polymorphisms of 11 cytokine genes Journal of Gastroenterology and Hepatology. ,vol. 22, pp. 729- 737 ,(2007) , 10.1111/J.1440-1746.2007.04934.X
YOSHINORI WATANABE, NOBUO AOYAMA, TOSHIYUKI SAKAI, DAISUKE SHIRASAKA, SHUJI MAEKAWA, KOHEI KURODA, CASMIR WAMBURA, TAKAO TAMURA, YOSHISUKE NOSE, MASATO KASUGA, HLA‐DQB1 locus and gastric cancer in Helicobacter pylori infection Journal of Gastroenterology and Hepatology. ,vol. 21, pp. 420- 424 ,(2006) , 10.1111/J.1440-1746.2005.04112.X
T. MASAOKA, H. SUZUKI, K. KURABAYASHI, Y. NOMOTO, T. NISHIZAWA, M. MORI, T. HIBI, Could frameshift mutations in the frxA and rdxA genes of Helicobacter pylori be a marker for metronidazole resistance?: FRXA AND RDXA GENES TO METRONIDAZOLE RESISTANCE IN H. PYLORI Alimentary Pharmacology & Therapeutics. ,vol. 24, pp. 81- 87 ,(2007) , 10.1111/J.1365-2036.2006.00029.X
Manabu Sawaya, Tetsuro Yoshimura, Tadashi Shimoyama, Akihiro Munakata, Shinsaku Fukuda, Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori. Journal of Clinical Gastroenterology. ,vol. 42, pp. 351- 355 ,(2008) , 10.1097/MCG.0B013E318054493E
FJGM Kubben, CFM Sier, MJW Meijer, M Van Den Berg, JJ Van Der Reijden, G Griffioen, CJH Van De Velde, CBHW Lamers, HW Verspaget, Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. British Journal of Cancer. ,vol. 95, pp. 744- 751 ,(2006) , 10.1038/SJ.BJC.6603307
Toshihiro Nishizawa, Hidekazu Suzuki, Toshifumi Hibi, Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication Journal of Clinical Biochemistry and Nutrition. ,vol. 44, pp. 119- 124 ,(2009) , 10.3164/JCBN.08-220R
Hidekazu Suzuki, Hiroe Muraoka, Toshifumi Hibi, Toshihiro Nishizawa, Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of Helicobacter pylori with gyrA Mutation Antimicrobial Agents and Chemotherapy. ,vol. 53, pp. 1720- 1721 ,(2009) , 10.1128/AAC.00049-09
Susumu Take, Motowo Mizuno, Kuniharu Ishiki, Yasuhiro Nagahara, Tomowo Yoshida, Kenji Yokota, Keiji Oguma, Hiroyuki Okada, Yasushi Shiratori, The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. The American Journal of Gastroenterology. ,vol. 100, pp. 1037- 1042 ,(2005) , 10.1111/J.1572-0241.2005.41384.X